Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7075)
All Articles published online
|
Publishing Process of This Article
|
Oct 15, 2019 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Recio-Boiles A, Veeravelli S, Vondrak J, Babiker HM, Scott AJ, Shroff RT, Patel H, Elquza E, McBride A. Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism. World J Gastrointest Oncol 2019; 11(10): 866-876 [PMID: 31662825 DOI: 10.4251/wjgo.v11.i10.866] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i10/866.htm |
| Number | Citing Articles |
| 1 |
Tarinee Rungjirajittranon, Weerapat Owattanapanich, Yingyong Chinthammitr, Theera Ruchutrakool, Bundarika Suwanawiboon. Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis. Thrombosis Journal 2022; 20(1) doi: 10.1186/s12959-022-00399-7
|
| 2 |
Shinji Rho, Chris Wang, Seyed Hamed Hosseini Dehkordi, James J. Sears, Z. Ian Hu. Bleeding and thrombotic events in bevacizumab-treated patients with colorectal cancer on novel oral anticoagulants and antiplatelet medications. American Heart Journal Plus: Cardiology Research and Practice 2023; 27: 100283 doi: 10.1016/j.ahjo.2023.100283
|
| 3 |
Maryam R. Hussain, Faisal S. Ali, Dhiran Verghese, Phyo Thazin Myint, Mubashir Ahmed, Zimu Gong, Yasmin Gerais, Mahrukh Siddiqui, Jenny J. Lin, Kevin Troy. Factor Xa inhibitors versus low molecular weight heparin for the treatment of cancer associated venous thromboembolism; A meta-analysis of randomized controlled trials and non-randomized studies. Critical Reviews in Oncology/Hematology 2022; 169: 103526 doi: 10.1016/j.critrevonc.2021.103526
|
| 4 |
Victoria R Nachar, Allison J Schepers. Clinical controversies in the treatment of cancer-associated venous thromboembolism. Journal of Oncology Pharmacy Practice 2021; 27(4): 939 doi: 10.1177/1078155220984371
|
| 5 |
Damon E. Houghton, Danielle T. Vlazny, Ana I. Casanegra, Nichole Brunton, David A. Froehling, Ryan A. Meverden, David O. Hodge, Lisa G. Peterson, Robert D. McBane, Waldemar E. Wysokinski. Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism. Mayo Clinic Proceedings 2021; 96(11): 2793 doi: 10.1016/j.mayocp.2021.04.026
|
| 6 |
William J. Chapin, Preeti Sudheendra, Luis Goity, Deepak Sudheendra. Epidemiology, Prevention, Diagnosis, and Management of Venous Thromboembolism in Gastrointestinal Cancers. Digestive Disease Interventions 2020; 4(03): 248 doi: 10.1055/s-0040-1716738
|
| 7 |
Mouhand F. H. Mohamed, Mohamad Nabil ElShafei, Mohamed Badie Ahmed, Lina O. Abdalla, Israa Ahmed, Abdel-Naser Elzouki, Mohammed ibn-mas’ud Danjuma. The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis 2021; 27 doi: 10.1177/1076029620940046
|
| 8 |
Tirath Patel, Taha Nadeem, Usman Shahbaz, Fatima Tanveer, Muneeb Ahsan, Usman Saeed, Abdullah Ahmed, Vinesh Kumar, Syed M Ibne Ali Jaffari, Mohammad U Zaman, Satesh Kumar, Mahima Khatri, Giustino Varrassi, Prasanthi Vanga. Comparative Efficacy of Direct Oral Anticoagulants and Low-Molecular-Weight Heparin in Cancer-Associated Thromboembolism: A Systematic Review and Meta-Analysis. Cureus 2023; doi: 10.7759/cureus.41071
|
| 9 |
Mercedes Salgado, Elena Brozos-Vázquez, Begoña Campos, Paula González-Villarroel, María Eva Pérez, María Lidia Vázquez-Tuñas, David Arias. Venous Thromboembolism In Cancer Patients: “From Evidence to Care”. Clinical and Applied Thrombosis/Hemostasis 2022; 28 doi: 10.1177/10760296221098717
|
| 10 |
Maryam F Baloch, Adedimeji V Adepoju, Vaibhavkumar Falki, Mohsin Hajjaj, Tatiana Habet, Karina Habet, Amtul Mahrosh, Sumana Kundu, Janvi Kataria, Midhun Mathew, Tugba Saka, Mohammed Al-Tawil. Comparative Efficacy of Oral Apixaban and Subcutaneous Low Molecular Weight Heparins in the Treatment of Cancer-Associated Thromboembolism: A Meta-Analysis. Cureus 2023; doi: 10.7759/cureus.43447
|
| 11 |
Seohyun (Claudia) Choi, Jessica Wilczynski, Danielle Tompkins, Jimmy Gonzalez. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2020; 42: 337 doi: 10.1016/bs.seda.2020.08.011
|